Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice

Peptides

Volumn 28, Issue 9, 2007, Pages 1674-1679

  Fujii, Harumi ^a   Ishihama, Toshihiro ^a   Ago, Yukio ^a   Shintani, Norihito ^a   Kakuda, Michiya ^b   Hashimoto, Hitoshi ^a,b   Baba, Akemichi ^a   Matsuda, Toshio ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Behavioral sensitization; Locomotor activity; Methamphetamine (METH); PACAP; PACAP mice

Indexed keywords

DOPAMINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; METHAMPHETAMINE; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR CONTROL; COMPARATIVE STUDY; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; HABITUATION; HYPERACTIVITY; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NEUROCHEMISTRY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN FUNCTION; SEROTONIN BRAIN LEVEL; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; FEMALE; GENOTYPE; MALE; METHAMPHETAMINE; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; MICRODIALYSIS; MOTOR ACTIVITY; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PREFRONTAL CORTEX; SEROTONIN; TIME FACTORS;

MUS;

EID: 34548405083     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.06.012     Document Type: Article

References (23)

1. 1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology 45 (2003) 1050-1056
2. 1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice. Neuropharmacology 51 (2006) 914-922
3. 1A receptor-mediated dopamine release in vivo in the frontal cortex of mice. J Neurochem 83 (2002) 353-359
4. Badiani A., Oates M.M., Day H.E., Watson S.J., Akil H., and Robinson T.E. Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J Neurosci 18 (1998) 10579-10593
5. Bardo M.T., Bowling S.L., and Pierce R.C. Changes in locomotion and dopamine neurotransmission following amphetamine, haloperidol, and exposure to novel environmental stimuli. Psychopharmacology 101 (1990) 338-343
6. Crombag H.S., Badiani A., Chan J., Dell'Orco J., Dineen S.P., and Robinson T.E. The ability of environmental context to facilitate psychomotor sensitization to amphetamine can be dissociated from its effect on acute drug responsiveness and on conditioned responding. Neuropsychopharmacology 24 (2001) 680-690
7. Franklin K.B.J., and Paxinos G. The mouse brain in stereotaxic coordinates (1997), Academic Press Inc., San Diego
8. Ghatei M.A., Takahashi K., Suzuki Y., Gardiner J., Jones P.M., and Bloom S.R. Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues. J Encocrinol 136 (1993) 159-166
9. Hashimoto H., Shintani N., and Baba A. New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice. Ann NY Acad Sci 1070 (2006) 75-89
10. Hashimoto H., Shintani N., Tanaka K., Mori W., Hirose M., Matsuda T., et al. Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci USA 98 (2001) 13355-13360
11. Kalivas P.W., and Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev 16 (1991) 223-244
12. Kiyatkin E.A. State-dependent peculiarities of cocaine-induced behavioral sensitization and their possible reasons. Int J Neurosci 67 (1992) 93-103
13. Masuo Y., Suzuki N., Matsumoto H., Tokito F., Matsumoto Y., Tsuda M., et al. Regional distribution of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat central nervous system as determined by sandwich-enzyme immunoassay. Brain Res 602 (1993) 57-63
14. 1A receptor agonist/antagonist in mice. Synapse 60 (2006) 479-484
15. Pigins H.D., Stamp J.A., Burns J., Rusak B., and Semba K. Distribution of pituitary adenylate cyclase activating polypeptide (PACAP) immunoreactivity in the hypothalamus and extended amygdala of the rat. J Comp Neurol 376 (1996) 278-294
16. Robinson T.E., and Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res 396 (1986) 157-198
17. Russell R.L., and Pihl R.O. The effect of dose, novelty, and exploration on amphetamine-produced stereotyped behavior. Psychopharmacology 60 (1978) 93-100
18. Salomon L., Lanteri C., Glowinski J., and Tassin J.P. Behavioral sensitization to amphetamine results from an uncoupling between noradrenergic and serotonergic neurons. Proc Natl Acad Sci USA 103 (2006) 7476-7481
19. -/-). Ann NY Acad Sci 1070 (2006) 545-549
20. Solanto M.V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration. Behav Brain Res 94 (1998) 127-152
21. Solanto M.V. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav Brain Res 130 (2002) 65-71
22. Tanaka K., Shintani N., Hashimoto H., Kawagishi N., Ago Y., Matsuda T., et al. Psychostimulant-induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice. J Neurosci 26 (2006) 5091-5097
23. Vanderschuren L.J., and Kalivas P.W. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151 (2000) 99-120